These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30297368)

  • 1. Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
    Bartelt LA; Bolick DT; Kolling GL; Stebbins E; Huston CD; Guerrant RL; Hoffman PS
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297368
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
    Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.
    Warren CA; van Opstal E; Ballard TE; Kennedy A; Wang X; Riggins M; Olekhnovich I; Warthan M; Kolling GL; Guerrant RL; Macdonald TL; Hoffman PS
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4103-11. PubMed ID: 22585229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
    Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic efficacy on
    Diawara EH; François A; Stachulski AV; Razakandrainibe R; Costa D; Favennec L; Rossignol JF; Gargala G
    Parasitology; 2021 Jul; 148(8):975-984. PubMed ID: 33775260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.
    Li X; Brasseur P; Agnamey P; Leméteil D; Favennec L; Ballet JJ; Rossignol JF
    Folia Parasitol (Praha); 2003 Mar; 50(1):19-22. PubMed ID: 12735719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
    Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.
    Rueda C; Fenoy S; Simón F; Del Aguila C
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1150-2. PubMed ID: 18160525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori.
    Hoffman PS; Bruce AM; Olekhnovich I; Warren CA; Burgess SL; Hontecillas R; Viladomiu M; Bassaganya-Riera J; Guerrant RL; Macdonald TL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4703-12. PubMed ID: 24890599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
    Moustafa MA
    J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model.
    Costa LB; JohnBull EA; Reeves JT; Sevilleja JE; Freire RS; Hoffman PS; Lima AA; Oriá RB; Roche JK; Guerrant RL; Warren CA
    J Parasitol; 2011 Dec; 97(6):1113-20. PubMed ID: 21711105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of
    Buckner FS; Ranade RM; Gillespie JR; Shibata S; Hulverson MA; Zhang Z; Huang W; Choi R; Verlinde CLMJ; Hol WGJ; Ochida A; Akao Y; Choy RKM; Van Voorhis WC; Arnold SLM; Jumani RS; Huston CD; Fan E
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.
    Schnyder M; Kohler L; Hemphill A; Deplazes P
    Vet Parasitol; 2009 Mar; 160(1-2):149-54. PubMed ID: 19062195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
    Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
    Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box.
    Bessoff K; Spangenberg T; Foderaro JE; Jumani RS; Ward GE; Huston CD
    Antimicrob Agents Chemother; 2014 May; 58(5):2731-9. PubMed ID: 24566188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
    Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
    Abdou AG; Harba NM; Afifi AF; Elnaidany NF
    Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
    Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.